Hyoung Won Bae1, Seungsoo Rho2, Hye Sun Lee3, Naeun Lee1, Samin Hong1, Gong Je Seong1, Kyung Rim Sung4, Chan Yun Kim1. 1. Department of Ophthalmology, Severance Hospital, Institute of Vision Research, Yonsei University College of Medicine, Seoul, Korea. 2. Department of Ophthalmology, CHA Bundang Medical Center, CHA University, Seongnam, Korea. 3. Department of Research Affairs, Biostatistics Collaboration Unit, Yonsei University College of Medicine, Seoul, Korea. 4. Department of Ophthalmology, College of Medicine, University of Ulsan, Asan Medical Center, Seoul, Korea.
Abstract
PURPOSE: To classify medically treated open-angle glaucoma (OAG) by the pattern of progression using hierarchical cluster analysis, and to determine OAG progression characteristics by comparing clusters. METHODS: Ninety-five eyes of 95 OAG patients who received medical treatment, and who had undergone visual field (VF) testing at least once per year for 5 or more years. OAG was classified into subgroups using hierarchical cluster analysis based on the following five variables: baseline mean deviation (MD), baseline visual field index (VFI), MD slope, VFI slope, and Glaucoma Progression Analysis (GPA) printout. After that, other parameters were compared between clusters. RESULTS: Two clusters were made after a hierarchical cluster analysis. Cluster 1 showed -4.06 ± 2.43 dB baseline MD, 92.58% ± 6.27% baseline VFI, -0.28 ± 0.38 dB per year MD slope, -0.52% ± 0.81% per year VFI slope, and all "no progression" cases in GPA printout, whereas cluster 2 showed -8.68 ± 3.81 baseline MD, 77.54 ± 12.98 baseline VFI, -0.72 ± 0.55 MD slope, -2.22 ± 1.89 VFI slope, and seven "possible" and four "likely" progression cases in GPA printout. There were no significant differences in age, sex, mean IOP, central corneal thickness, and axial length between clusters. However, cluster 2 included more high-tension glaucoma patients and used a greater number of antiglaucoma eye drops significantly compared with cluster 1. CONCLUSIONS: Hierarchical cluster analysis of progression patterns divided OAG into slow and fast progression groups, evidenced by assessing the parameters of glaucomatous progression in VF testing. In the fast progression group, the prevalence of high-tension glaucoma was greater and the number of antiglaucoma medications administered was increased versus the slow progression group. Copyright 2014 The Association for Research in Vision and Ophthalmology, Inc.
PURPOSE: To classify medically treated open-angle glaucoma (OAG) by the pattern of progression using hierarchical cluster analysis, and to determine OAG progression characteristics by comparing clusters. METHODS: Ninety-five eyes of 95 OAG patients who received medical treatment, and who had undergone visual field (VF) testing at least once per year for 5 or more years. OAG was classified into subgroups using hierarchical cluster analysis based on the following five variables: baseline mean deviation (MD), baseline visual field index (VFI), MD slope, VFI slope, and Glaucoma Progression Analysis (GPA) printout. After that, other parameters were compared between clusters. RESULTS: Two clusters were made after a hierarchical cluster analysis. Cluster 1 showed -4.06 ± 2.43 dB baseline MD, 92.58% ± 6.27% baseline VFI, -0.28 ± 0.38 dB per year MD slope, -0.52% ± 0.81% per year VFI slope, and all "no progression" cases in GPA printout, whereas cluster 2 showed -8.68 ± 3.81 baseline MD, 77.54 ± 12.98 baseline VFI, -0.72 ± 0.55 MD slope, -2.22 ± 1.89 VFI slope, and seven "possible" and four "likely" progression cases in GPA printout. There were no significant differences in age, sex, mean IOP, central corneal thickness, and axial length between clusters. However, cluster 2 included more high-tension glaucomapatients and used a greater number of antiglaucoma eye drops significantly compared with cluster 1. CONCLUSIONS: Hierarchical cluster analysis of progression patterns divided OAG into slow and fast progression groups, evidenced by assessing the parameters of glaucomatous progression in VF testing. In the fast progression group, the prevalence of high-tension glaucoma was greater and the number of antiglaucoma medications administered was increased versus the slow progression group. Copyright 2014 The Association for Research in Vision and Ophthalmology, Inc.
Authors: Janelle Tong; Jack Phu; Sieu K Khuu; Nayuta Yoshioka; Agnes Y Choi; Lisa Nivison-Smith; Robert E Marc; Bryan W Jones; Rebecca L Pfeiffer; Michael Kalloniatis; Barbara Zangerl Journal: Am J Ophthalmol Date: 2019-05-10 Impact factor: 5.258
Authors: Vahid Mohammadzadeh; Erica Su; Alessandro Rabiolo; Lynn Shi; Sepideh Heydar Zadeh; Simon K Law; Anne L Coleman; Joseph Caprioli; Robert E Weiss; Kouros Nouri-Mahdavi Journal: Am J Ophthalmol Date: 2021-12-21 Impact factor: 5.488
Authors: Jack Phu; Sieu K Khuu; Lisa Nivison-Smith; Barbara Zangerl; Agnes Yiu Jeung Choi; Bryan W Jones; Rebecca L Pfeiffer; Robert E Marc; Michael Kalloniatis Journal: Invest Ophthalmol Vis Sci Date: 2017-09-01 Impact factor: 4.799